Used primarily as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of selective enzyme inhibitors and central nervous system agents. Its fluorinated benzyl structure enhances binding affinity and metabolic stability in drug candidates. Commonly employed in the preparation of hydrazine-based protease inhibitors and monoamine oxidase (MAO) inhibitors. Also utilized in research settings for labeling and conjugation in medicinal chemistry due to the reactivity of the hydrazine group. Suitable for solid-phase synthesis and solution-phase coupling reactions in the production of bioactive molecules.